Kalpataru Projects International Limited (KPIL.NS)
INR 1294.6
(-1.5%)
INR 1294.6
(-1.5%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 196.26 Billion | 163.61 Billion | 146.18 Billion | 128.42 Billion | 125.8 Billion | 107.2 Billion |
| Cost of Revenue | 144.19 Billion | 123.84 Billion | 112.37 Billion | 94.21 Billion | 93.55 Billion | 79.94 Billion |
| Gross Profit | 52.06 Billion | 39.77 Billion | 33.8 Billion | 34.2 Billion | 32.24 Billion | 27.26 Billion |
| Operating Expenses | 22.36 Billion | 29.99 Billion | 24.33 Billion | 21.82 Billion | 20.41 Billion | 15.43 Billion |
| Selling, General and Administrative Expenses | 4.74 Billion | 4.86 Billion | 4.29 Billion | 4.23 Billion | 2.9 Billion | 2.62 Billion |
| Research and Development Expenses | 194.8 Million | 170.1 Million | 155.9 Million | 123 Million | 139.8 Million | 82.9 Million |
| Other Expenses | 17.43 Billion | 400 Million | 291.9 Million | 44.7 Million | 52.4 Million | 93.17 Million |
| Cost and Expenses | 166.56 Billion | 153.83 Billion | 136.71 Billion | 116.04 Billion | 113.97 Billion | 95.38 Billion |
| Operating Income | 29.69 Billion | 10.18 Billion | 9.17 Billion | 11.71 Billion | 11.53 Billion | 11.63 Billion |
| Interest Expense | 6.96 Billion | 4.67 Billion | 3.84 Billion | 4.34 Billion | 5 Billion | 3.92 Billion |
| Income Tax Expense | 1.85 Billion | 2.07 Billion | 1.61 Billion | 2.83 Billion | 2.58 Billion | 2.74 Billion |
| Earnings before Tax | 7.01 Billion | 6.42 Billion | 6.96 Billion | 9.45 Billion | 6.47 Billion | 7.61 Billion |
| Net Income | 5.09 Billion | 4.4 Billion | 5.4 Billion | 6.71 Billion | 3.89 Billion | 4.66 Billion |
| Earnings Per Share Basic | 31.37 | 29.06 | 36.28 | 44.25 | 25.25 | 30.42 |
| Earnings Per Share Diluted | 31.37 | 29.06 | 36.28 | 44.25 | 25.25 | 30.42 |
| Weighted Average Shares Outstanding | 162.44 Million | 151.69 Million | 148.9 Million | 151.65 Million | 154.26 Million | 153.46 Million |
| Weighted Average Shares Outstanding (Diluted) | 162.44 Million | 151.69 Million | 148.9 Million | 151.65 Million | 154.26 Million | 153.46 Million |
| Gross Margin | 0.27 | 0.24 | 0.23 | 0.27 | 0.26 | 0.25 |
| EBIT Margin | 0.10 | 0.09 | 0.09 | 0.12 | 0.12 | 0.13 |
| Profit Margin | 0.03 | 0.03 | 0.04 | 0.05 | 0.03 | 0.04 |
| EBITDA | 18.7 Billion | 16.46 Billion | 15.86 Billion | 18.88 Billion | 16.03 Billion | 14.53 Billion |
| Earnings Before Tax Margin | 0.15 | 0.06 | 0.06 | 0.09 | 0.09 | 0.11 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 49.29 Billion | 45.87 Billion | 196.26 Billion | 59.71 Billion | 48.96 Billion | 45.18 Billion |
| Cost of Revenue | 37.28 Billion | 40.31 Billion | 169.91 Billion | 50.42 Billion | 37.15 Billion | 34.35 Billion |
| Gross Profit | 12.01 Billion | 5.56 Billion | 26.35 Billion | 9.29 Billion | 11.81 Billion | 10.83 Billion |
| Operating Expenses | 8.8 Billion | 2.97 Billion | 14.8 Billion | 5.96 Billion | 8.78 Billion | 8.26 Billion |
| Selling, General and Administrative Expenses | 2.61 Billion | 2.97 Billion | - | 5.96 Billion | 3.09 Billion | 2.99 Billion |
| Research and Development Expenses | - | - | - | 194.8 Million | - | - |
| Other Expenses | 8.8 Billion | 220 Million | 640 Million | 200 Million | 140 Million | 120 Million |
| Cost and Expenses | 46.08 Billion | 43.28 Billion | 184.71 Billion | 56.38 Billion | 45.93 Billion | 42.61 Billion |
| Operating Income | 3.21 Billion | 2.59 Billion | 11.55 Billion | 3.33 Billion | 3.17 Billion | 2.69 Billion |
| Interest Expense | 1.5 Billion | 1.44 Billion | 5.18 Billion | 1.42 Billion | 1.24 Billion | 1.37 Billion |
| Income Tax Expense | 624.6 Million | 530 Million | 1.85 Billion | 420 Million | 490 Million | 420 Million |
| Earnings before Tax | 1.88 Billion | 1.37 Billion | 7.01 Billion | 2.11 Billion | 1.93 Billion | 1.32 Billion |
| Net Income | 1.25 Billion | 930 Million | 5.09 Billion | 1.64 Billion | 1.41 Billion | 890 Million |
| Earnings Per Share Basic | 7.73 | 5.73 | - | 10.11 | 8.68 | 5.48 |
| Earnings Per Share Diluted | 7.73 | 5.73 | - | 10.11 | 8.68 | 5.48 |
| Weighted Average Shares Outstanding | 162.35 Million | 162.44 Million | 162.57 Million | 163.2 Million | 162.44 Million | 162.44 Million |
| Weighted Average Shares Outstanding (Diluted) | 162.35 Million | 162.44 Million | 162.57 Million | 163.2 Million | 162.44 Million | 162.44 Million |
| Gross Margin | 0.24 | 0.12 | 0.13 | 0.16 | 0.24 | 0.24 |
| EBIT Margin | 0.09 | 0.08 | - | 0.08 | 0.09 | 0.08 |
| Profit Margin | 0.03 | 0.02 | 0.03 | 0.03 | 0.03 | 0.02 |
| EBITDA | 4.55 Billion | 3.78 Billion | - | 4.52 Billion | 4.38 Billion | 3.82 Billion |
| Earnings Before Tax Margin | 0.07 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 |
TKO
AUI
GFSA3
JBCHEPHARM
RFG
EQFN